Skip to main content
SpringerLink
Log in

Should elderly heart failure patients be treated with β-blockade therapy?

  • Practice Point
  • Published:

From Nature Clinical Practice Cardiovascular Medicine

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Remme WJ and Swedberg K (2001) Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 22: 1527–1560

    Article  CAS  Google Scholar 

  2. The CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 316: 1429–1435

  3. The SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325: 293–302

  4. Erdmann E et al. (2001) Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure. Eur J Heart Fail 3: 469–479

    Article  CAS  Google Scholar 

  5. Packer M et al. (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344: 1651–1658

    Article  CAS  Google Scholar 

  6. Cleland JGF et al. (2004) Clinical trials update from the European Society of Cardiology: SENIORS, ACES, PROVE-IT, ACTION, and the HF-ACTION trial. Eur J Heart Fail 6: 787–791

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Hannah Camm, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. the Göteborg University and Senior Physician in the Department of Medicine, Cardiovascular Institute, Sahlgrenska University Hospital/Östra, Göteborg, Sweden

    Karl Swedberg

Authors
  1. Karl Swedberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karl Swedberg.

Ethics declarations

Competing interests

K Swedberg has received research support and honoraria from Astrazeneca, Roche, Glaxo SmithKline and other major cardiovascular pharmaceutical companies.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Swedberg, K. Should elderly heart failure patients be treated with β-blockade therapy?. Nat Rev Cardiol 2, 14–15 (2005). https://doi.org/10.1038/ncpcardio0077

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0077

  • Springer Nature Limited

Search

Navigation